Companies Dominating the Flash Glucose Monitoring Landscape
- Novo Nordisk A/S
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- DexCom, Inc.
- GlySens Incorporated
- Medtronic plc
- Insulet Corporation
- Ypsomed Holding AG
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories
- Tandem Diabetes Care, Inc.
- ForaCare, Inc.
Browse Key Market Insights with Data Illustration:
In the News
- DexCom, Inc. announced the its new device-ONE Continuous Glucose Monitoring System, is slated for release in United Kingdom in this May. In the UK, Dexcom ONE is estimated to be a more affordable and accessible real-time CGM (rt-CGM) system for people with diabetes.
- Novo Nordisk A/S announced that Ozempic 2.0 mg has been approved by the US Food and Drug Administration (FDA). Ozempic has now been approved for treating type 2 diabetes in adults at doses of 0.5 mg, 1.0 mg, and 2.0 mg in the United States.
